These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9570379)

  • 61. Mapping the X(+1) binding site of the Grb2-SH2 domain with alpha,alpha-disubstituted cyclic alpha-amino acids.
    García-Echeverría C; Gay B; Rahuel J; Furet P
    Bioorg Med Chem Lett; 1999 Oct; 9(20):2915-20. PubMed ID: 10571147
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Highly potent inhibitors of the Grb2-SH2 domain.
    Schoepfer J; Fretz H; Gay B; Furet P; García-Echeverría C; End N; Caravatti G
    Bioorg Med Chem Lett; 1999 Jan; 9(2):221-6. PubMed ID: 10021933
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain.
    Li P; Peach ML; Zhang M; Liu H; Yang D; Nicklaus M; Roller PP
    Bioorg Med Chem Lett; 2003 Mar; 13(5):895-9. PubMed ID: 12617916
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 8-O-Methylsclerotiorinamine, antagonist of the Grb2-SH2 domain, isolated from Penicillium multicolor.
    Nam JY; Kim HK; Kwon JY; Han MY; Son KH; Lee UC; Choi JD; Kwon BM
    J Nat Prod; 2000 Sep; 63(9):1303-5. PubMed ID: 11000046
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis and evaluation of phosphopeptides containing iminodiacetate groups as binding ligands of the Src SH2 domain.
    Ye G; Schuler AD; Ahmadibeni Y; Morgan JR; Faruqui A; Huang K; Sun G; Zebala JA; Parang K
    Bioorg Chem; 2009 Aug; 37(4):133-42. PubMed ID: 19539345
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode.
    Rahuel J; Gay B; Erdmann D; Strauss A; Garcia-Echeverría C; Furet P; Caravatti G; Fretz H; Schoepfer J; Grütter MG
    Nat Struct Biol; 1996 Jul; 3(7):586-9. PubMed ID: 8673601
    [No Abstract]   [Full Text] [Related]  

  • 67. SH2 domain binding to phosphopeptide ligands: potential for drug targeting.
    Kasembeli MM; Xu X; Tweardy DJ
    Front Biosci (Landmark Ed); 2009 Jan; 14(3):1010-22. PubMed ID: 19273114
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NMR Relaxation Dispersion Experiments to Study Phosphopeptide Recognition by SH2 Domains: The Grb2-SH2-Phosphopeptide Encounter Complex.
    Almeida FCL; Sanches K; Caruso IP; Melo FA
    Methods Mol Biol; 2023; 2705():135-151. PubMed ID: 37668973
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of SH2 ligands and identification of sites of interaction.
    Baca M
    Methods Mol Biol; 2004; 249():111-20. PubMed ID: 14573895
    [No Abstract]   [Full Text] [Related]  

  • 70. Inhibitor Library Screening of SH2 Domains Through Denaturation-Based Assays.
    de Araujo ED; Orlova A; Ashraf QF; Moriggl R; Gunning PT
    Methods Mol Biol; 2023; 2705():213-223. PubMed ID: 37668976
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fluorescence Anisotropy and Polarization in the Characterization of Biomolecular Association Processes and Their Application to Study SH2 Domain Binding Affinity.
    Bobone S; Storti C; Calligari P; Stella L
    Methods Mol Biol; 2023; 2705():93-112. PubMed ID: 37668971
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Amino propynyl benzoic acid building block in rigid spacers of divalent ligands binding to the Syk SH2 domains with equally high affinity as the natural ligand.
    Dekker FJ; de Mol NJ; Fischer MJ; Liskamp RM
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1241-4. PubMed ID: 12657254
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rate enhancement of an interfacial biochemical reaction through localization of substrate and enzyme by an adaptor domain.
    Li J; Nayak S; Mrksich M
    J Phys Chem B; 2010 Nov; 114(46):15113-8. PubMed ID: 21047083
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A High-Throughput Fluorescence Polarization-Based Assay for the SH2 Domain of STAT4.
    Berg A; Gräber M; Schmutzler S; Hoffmann R; Berg T
    Methods Protoc; 2022 Nov; 5(6):. PubMed ID: 36548135
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of Lipid Binding Modulators Using the Protein-Lipid Overlay Assay.
    Tang TX; Xiong W; Finkielstein CV; Capelluto DGS
    Methods Mol Biol; 2017; 1647():197-206. PubMed ID: 28809004
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DRUGGING "UNDRUGGABLE" DISEASE-CAUSING PROTEINS: FOCUS ON SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 3.
    Tweardy DJ
    Trans Am Clin Climatol Assoc; 2022; 132():61-76. PubMed ID: 36196170
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A screening method of SH2 domain ligands and blockers using a solid phase binding.
    Koh WS; Yoon SY; Lee EK; Lee EK; Kwon BM; Kim JW; Han MY
    Cancer Lett; 1997 Nov; 120(1):1-7. PubMed ID: 9570379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain.
    de Mol NJ; Catalina MI; Fischer MJ; Broutin I; Maier CS; Heck AJ
    Biochim Biophys Acta; 2004 Jul; 1700(1):53-64. PubMed ID: 15210125
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
    Gram H; Schmitz R; Zuber JF; Baumann G
    Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.